Enobia, Laureate Pharma Inc. deal

Laureate will develop and manufacture Phase I batches of Enobia's sPHEX Metallo Peptidase to treat X-linked hypophosphatemia (XLH). Enobia plans to start Phase I trials of the recombinant enzyme in th...